173 related articles for article (PubMed ID: 34699028)
1. Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases.
Weng HY; Yan T; Qiu WW; Xi C; Hou LY; Yang ZL; Qiu ZL
Endocrine; 2022 Feb; 75(2):495-507. PubMed ID: 34699028
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
3.
Parvathareddy SK; Siraj AK; Iqbal K; Qadri Z; Ahmed SO; Al-Rasheed M; AlQatie AA; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():808298. PubMed ID: 35360077
[TBL] [Abstract][Full Text] [Related]
4. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
5. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid microcarcinoma: an over-treated malignancy?
Wang TS; Goffredo P; Sosa JA; Roman SA
World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670
[TBL] [Abstract][Full Text] [Related]
8. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
[No Abstract] [Full Text] [Related]
10. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
13. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
14. Role of Diagnostic
Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Vasileiadis I; Karakostas E; Charitoudis G; Stavrianaki A; Kapetanakis S; Kouraklis G; Karatzas T
Eur J Clin Invest; 2012 Jun; 42(6):657-64. PubMed ID: 22168782
[TBL] [Abstract][Full Text] [Related]
16. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
[TBL] [Abstract][Full Text] [Related]
17. Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study.
Shafique K; LiVolsi VA; Montone K; Baloch ZW
Endocr Pathol; 2018 Dec; 29(4):339-345. PubMed ID: 30196478
[TBL] [Abstract][Full Text] [Related]
18. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
